下肢旁路与开放腹主动脉瘤修复术后标准化胰岛素输注方案的前瞻性血糖控制研究
单中心前瞻性研究纳入2013年1月至2015年3月择期下肢旁路(n=53,62%)和开放腹主动脉瘤修复(n=33,38%)患者,采用标准化胰岛素输注方案进行术后血糖控制。主要终点为最优血糖控制(≥85%血糖值在80-150 mg/dL)。开放腹主动脉瘤修复后最优控制率高于下肢旁路(85% vs. 64%,P=0.04);下肢旁路最优控制组住院时间更短(4.2 vs. 7.3天,P=0.02)且住院费用更低(中位$25,012 vs. $28,944,P=0.02),但手术部位感染率未降低。
要点
- 标准化胰岛素输注方案可实现术后血糖控制,但低血糖发生率较高(中度37%,重度7%)。
- 下肢旁路术后最优血糖控制与更短住院时间和更低费用相关。
- 最优血糖控制未降低手术部位感染等并发症发生率。
核心结论
- 下肢旁路和开放腹主动脉瘤修复术后高血糖常见,标准化胰岛素输注方案可有效改善血糖控制。
- 该方案风险低,下肢旁路术后最优血糖控制与住院时间缩短和费用降低相关。
- 最优围术期血糖控制未减少手术部位感染等并发症。
研究设计与样本
- 单中心前瞻性研究,纳入2013年1月至2015年3月择期下肢旁路(n=53,62%)和开放腹主动脉瘤修复(n=33,38%)患者。
- 主要终点为最优血糖控制,定义为≥85%的血糖值在80-150 mg/dL目标范围内;次优控制为<85%的血糖值在目标范围内。
主要发现
- 开放腹主动脉瘤修复后最优血糖控制率高于下肢旁路(85% vs. 64%,P=0.04)。
- 中度低血糖(<70 mg/dL)见于32例(37%)患者,重度低血糖(<50 mg/dL)见于6例(7%)患者。
- 下肢旁路术后30天手术部位感染率高于开放腹主动脉瘤修复(29% vs. 6%,P=0.01)。
- 下肢旁路术后最优与次优血糖控制组住院手术部位感染率(6% vs. 6%,P=1.0)和30天手术部位感染率(24% vs. 22%,P=1.0)相似。
- 开放腹主动脉瘤修复术后最优与次优血糖控制组住院手术部位感染率(4% vs. 0%,P=1.0)和30天手术部位感染率(4% vs. 0%,P=1.0)相似。
关键数值与推荐
- 最优血糖控制定义为≥85%的血糖值在80-150 mg/dL目标范围内。
- 下肢旁路术后最优控制组平均住院时间显著低于次优控制组(4.2 vs. 7.3天,P=0.02)。
- 下肢旁路术后最优控制组住院费用中位数低于次优控制组($25,012,四分位距$21,726-28,331 vs. $28,944,四分位距$24,773-41,270,P=0.02)。
- 开放腹主动脉瘤修复术后最优与次优控制组平均住院时间相似(5.8 vs. 6.4天,P=0.46)。
临床怎么用
- 下肢旁路和开放腹主动脉瘤修复术后可采用标准化胰岛素输注方案进行血糖控制,需警惕低血糖风险。
- 下肢旁路术后实现最优血糖控制可能缩短住院时间并降低住院费用。
- 不应仅以降低手术部位感染为目的强化术后血糖控制。
局限性
- 非随机设计,最优与次优血糖控制组间比较可能存在混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study is to examine the effect of moderate postoperative glycemic control in diabetic and nondiabetic patients undergoing infrainguinal bypass (INFRA) or open abdominal aortic aneurysm (OAAA) repair. METHODS: In a single center prospective study, we investigated postoperative glycemic control using a standardized insulin infusion protocol after elective INFRA bypass (n = 53, 62%) and OAAA repair (n = 33, 38%) between January 2013 and March 2015. The primary end point was optimal glycemic control, defined as having ≥85% of blood glucose values within the 80-150 mg/dL target range. Suboptimal glycemic control was defined as <85% of blood glucose values within the blood glucose target range. Secondary end points included in-hospital and 30-day surgical site infection (SSI) rates, composite adverse events, length of stay (LOS), and hospital cost. RESULTS: Optimal glycemic control was achieved more commonly after OAAA repair than INFRA bypass (85% vs. 64%, P = 0.04). Moderate hypoglycemia (<70 mg/dL) was observed in 32 (37%) patients, while severe hypoglycemia (<50 mg/dL) was observed in 6 (7%) patients. SSI at 30 days was more common after INFRA bypass (n = 15, 29%) than OAAA repair (n = 2, 6%) (P = 0.01). In-hospital (6% vs. 6%, P = 1.0) and 30-day (24% vs. 22%, P = 1.0) SSI rates were similar for optimal versus suboptimal glycemic control patients after INFRA bypass. In-hospital (4% vs. 0%, P = 1.0) and 30-day (4% vs. 0%, P = 1.0) SSI rates were similar for optimal versus suboptimal glycemic control patients after OAAA repair. The percentage of blood glucose > 250 mg/dL was similar for patients with and without SSI (3% vs. 2%, P = 0.36). Adverse cardiac and pulmonary events after INFRA bypass were similar between groups (9% vs. 21%, P = 0.23; 0% vs. 5%, P = 0.36, respectively). Adverse cardiac and pulmonary events after OAAA repair were similar between groups (2% vs. 0%, P = 1.0; 4% vs. 0%, P = 1.0, respectively). Mean LOS was significantly lower in patients with optimal glycemic control after INFRA bypass (4.2 vs. 7.3 days, P = 0.02). Mean LOS was similar after OAAA repair for patients with optimal and suboptimal control (5.8 vs. 6.4 days, P = 0.46). Inpatient hospital costs after INFRA bypass were lower for the group with optimal (median $25,012, interquartile range [IQ] range $21,726-28,331) versus suboptimal glycemic control (median $28,944, IQ range 24,773-41,270, P = 0.02). CONCLUSIONS: Postoperative hyperglycemia is common after INFRA bypass and OAAA repair and can be effectively ameliorated with an insulin infusion protocol. The protocol was low risk with reduced LOS and cost after INFRA bypass. Complications including SSI were not reduced in patients with optimal perioperative glycemic control.
引用
- Steely AM, Smith L, Callas PW, et al. Prospective Study of Postoperative Glycemic Control with a Standardized Insulin Infusion Protocol after Infrainguinal Bypass and Open Abdominal Aortic Aneurysm Repair. Ann Vasc Surg. 2017. PMID: 28502888. doi:10.1016/j.avsg.2017.04.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。